Share

    


Home / Search Results

Search Results

Search Again?

Filter By Topic

WSOS 2024 Laramie Meeting Wednesday May 22, 2024 University of Wyoming - Rochelle Gateway Center Laramie, WY Attendee Roster First Name Last Name Title Account Name Carlos Garcia PCT Ivinson Memorial Hospital, Meredith and Jeannie Ray Cancer Center Cindy Garnich Onclogy Social Worker Ivinson Memorial Hospital, Meredith and Jeannie Ray Cancer Center Cara Harshberger Clinical …
This content is being shared with permission from MJH Life Sciences. All content of Targeted Oncology is independently created and owned by MJH Life Sciences. SCOS ONCOLOGY DRUG NEWSLETTER M AY 2 0 2 4 FDA APPROVALS Idecabtagene vicleucel (ide-cel, Abecma) Idecabtagene vicleucel (ide-cel, Abecma) has been approved by the FDA for the treatment of patients with relapsed or refractory …
This content is being shared with permission from MJH Life Sciences. All content of Targeted Oncology is independently created and owned by MJH Life Sciences. TxSCO ONCOLOGY DRUG NEWSLETTER M AY 2 0 2 4 FDA APPROVALS Idecabtagene vicleucel (ide-cel, Abecma) Idecabtagene vicleucel (ide-cel, Abecma) has been approved by the FDA for the treatment of patients with relapsed or refractory …
This content is being shared with permission from MJH Life Sciences. All content of Targeted Oncology is independently created and owned by MJH Life Sciences. TACOS ONCOLOGY DRUG NEWSLETTER M AY 2 0 2 4 FDA APPROVALS Idecabtagene vicleucel (ide-cel, Abecma) Idecabtagene vicleucel (ide-cel, Abecma) has been approved by the FDA for the treatment of patients with relapsed or refractory …
OUR MISSION: Oncology State Societies at ACCC Engage & Succeed. WEST VIRGINIA ONCOLOGY SOCIETY 1801 Research Blvd, Suite 400, Rockville, Maryland 20850 Phone: 301.984.9496 www.wvosinfo.com APPLICATION FOR MEMBERSHIP Complete this application for annual membership (January 1–December 31) and email it to the Membership Department at ossmembership@accc-cancer.org. Please …
ACCC 2024 Hill Day Briefing - Oncology Drug Shortages Oncology Drug Shortages BACKGROUND: The Associa+on of Community Cancer Centers (ACCC) con+nues to be highly concerned about the ongoing shortages of pla+num-based chemotherapy agents, such as cispla+n and carbopla+n, that are used (individually or in combina+on) to treat and cure a wide range of cancers, including but not limited …
OUR MISSION: ROCKY MOUNTAIN ONCOLOGY SOCIETY 1801 Research Boulevard, Suite 400, Rockville, Maryland 20850 Phone: 301.984.9496 www.rmos-colorado.com Oncology State Societies at ACCC Engage & Succeed. APPLICATION FOR MEMBERSHIP Complete this application for annual membership (January 1–December 31) and email it to the Membership Department at …
OUR MISSION: Oncology State Societies at ACCC Engage & Succeed. TENNESSEE ONCOLOGY PRACTICE SOCIETY 1801 Research Blvd, Suite 400, Rockville, Maryland 20850 Phone: 301.984.9496 www.tops-tennessee.com APPLICATION FOR MEMBERSHIP Complete this application for annual membership (January 1–December 31) and email it to the Membership Department at …
2023 Membership One-Pagers I ABOUT West Virginia Oncology Society Founded in 2008, the West Virginia Oncology Society (WVOS) is a powerful community of multidisciplinary care providers involved in treating patients with cancer. WVOS is a state Chapter Member of the Association of Cancer Care Centers (ACCC) and a State Affiliate of the American Society of Clinical Oncology …
Founded in 1990, the Tennessee Oncology Practice Society (TOPS) is a powerful community of multidisciplinary care providers involved in treating patients with cancer. TOPS is a state Chapter Member of the Association of Cancer Care Centers (ACCC) and a State Affiliate of the American Society of Clinical Oncology. Members receive valuable educational content and innovative resources designed …
OUR MISSION: Oncology State Societies at ACCC Engage & Succeed. TENNESSEE ONCOLOGY PRACTICE SOCIETY 1801 Research Blvd, Suite 400, Rockville, Maryland 20850 Phone: 301.984.9496 www.tops-tennessee.com APPLICATION FOR MEMBERSHIP Complete this application for annual membership (January 1–December 31) and email it to the Membership Department at …
ASSOCIATION OF CANCER CARE CENTERS 1 Introduction The treatment landscape for patients with multiple myeloma has significantly expanded over the past decade with the introduction of several classes of agents and novel treatment regimens in the frontline, maintenance, and relapsed/refractory settings.1-3 The emergence of proteasome inhibitors, immunomod- ulatory agents, and anti-CD38 …
COMMUNICATING BIOMARKER TEST RESULTS ASSOCIATION OF CANCER CARE CENTERS Many terms are used to describe cancer biomarkers in patient education materials and literature for healthcare professionals. One of the greatest areas of confusion centers on the use of multigene panels designed to identify germline or somatic changes in DNA. The inconsistent use of terminology may …
GERMLINE VS SOMATIC TESTING FOR CANCER: HEREDITARY CANCER SYNDROMES ASSOCIATION OF CANCER CARE CENTERS Hereditary cancer syndromes, also known as inherited cancer syndrome or genetic cancer syndrome, describe gene changes that are passed down from parent to child and that may increase a person’s risk of developing a disease. Referred to as variants by the genetics community …
Reimagining ACCC Federal Issues Facing Colorado Practices Anna Pugh AGP Strategies Drug Shortages Telemedicine Research Funding Financial Toxicity Drug PricingIRA Non- Compete ChangeHC Hack Cancer Screening LDT Reform Prior Auth NavigationPBM Reform Payment Rules Patient Impacts Provider/ Practice Stresses GRIDLOCK Outlook …
PowerPoint Presentation State Legislative Efforts to Increase Patient Care Gray Jodon, MD RMOS Policy Committee Chair Hematologist/Oncologist, Denver Health Conflict of Interests •None to report Learning Objectives •Review the Colorado Prescription Drug Affordability Review Board and Advisory Council (PDAB/PDACC) upper payment limit selection process …
Germline and somatic testing for prostate cancer can improve outcomes and promote early detection and prevention, yet many patients are not aware of testing and the impact it can have on treatment options.
May 10, 2024
Emerging Influencers in NSCLC: How Can We Apply the Latest Tumor Testing and Treatment Strategies Across Actionable Biomarkers? This live, virtual program will feature expert faculty presenting on the latest findings supporting the inclusion of novel targeted therapies in the standard of care for NSCLC, as well as insights into new targets that may be actionable in the future. Learn More
ASSOCIATION OF CANCER CARE CENTERS 1 ASSOCIATION OF CANCER CARE CENTERS DIFFUSE LARGE B-CELL LYMPHOMA Effective Practices for Meaningful Care Conversations in a Changing Landscape 2 Effective Practices for Meaningful Care Conversations in a Changing Landscape Introduction Diffuse large B-cell lymphoma is the most common subtype of non-Hodgkin’s …